IP Library Assignment 035213/0333
Patent Assignment
Reel/Frame 035213/0333

Change of Name

Recorded: 2015-03-20 Pages: 12
Assignor
WATSON PHARMACEUTICALS, INC.
Executed: 2013-01-17
Assignee
ACTAVIS, INC.
400 INTERPACE PARKWAY, MORRIS CORPORATE CENTER III, PARSIPPANY, NEW JERSEY, 07054
Covered Property (1)
Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
Patent: 9,060,941 →
Application: 11/093,742 →
Publication: US 2005/0226928
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 27, 2005
From: LODIN, UNCHALEE; CARDINAL, JACK; NANGIA, AVINASH
To: ANDRX LABS LLC
Reel/Frame 020400/0016 →
Assignment of Assignor's Interest Jun 27, 2005
From: OKOCHI, KAZUHIRO
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 016719/0250 →
Assignment of Assignor's Interest Apr 6, 2009
From: ANDRX LABS, LLC
To: WATSON PHARMACEUTICALS, INC.
Reel/Frame 022509/0810 →